GRAL Stock Price
GRAIL, Inc.
GRAL stock price is $126.85 (-0.96% on the day), giving GRAIL, Inc. a market cap of $5.70B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
GRAL Stock Overview
- Price
- $126.84
- Previous close
- $128.08
- Open
- $125.88
- Market cap
- $5.70B
- 52-week range
- $37.50 - $166.47
- 1-year price target
- $134.33
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Exchange
- Nasdaq
- MarketXLS Rank
- 57
About GRAIL, Inc.
GRAIL, Inc., a commercial-stage healthcare company, focuses on developing technologies for early cancer detection in the United States and internationally. It provides Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company offers development services including support for ongoing clinical studies, pilot testing, research, and therapy development. It also develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GRAL | $126.85 | -1.0% | 101.43K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |